A retrospective cohort study in the Netherlands evaluated the real-world effectiveness of the biosimilar adalimumab Hyrimoz ...

Amjevita (adalimumab-atto) is a prescription drug used for certain inflammatory conditions, including rheumatoid arthritis and ulcerative colitis. Amjevita can cause side effects that range from mild ...

Jan. 2, 2003 — Abbott Laboratories received U.S. Food and Drug Administration (FDA) approval this week to market adalimumab (Humira), previously known as D2E7. The drug was approved for the treatment ...

Please provide your email address to receive an email when new articles are posted on . The risks for major adverse cardiac events and malignancy, excluding non-melanoma skin cancer, are similar ...

* Coherus Biosciences - ‍Both agents well tolerated, there were no clinical meaningful differential adverse events observed between two agents in study Source text for Eikon: Further company coverage: ...